Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00214_DB00322_nanopub.RAUTIP8KVXd6RhkD3K7Y7IxsTHa936FaaRwdkcPjOz6TM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00214_DB00322 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00214_DB00322 label "DDI between Torasemide and Floxuridine - Floxuridine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Floxuridine is initiated, discontinued or dose changed. [drugbank_resource:DB00214_DB00322]" assertion.
- drugbank_resource:DB00214_DB00322 identifier "drugbank_resource:DB00214_DB00322" assertion.
- drugbank_resource:DB00214_DB00322 title "DDI between Torasemide and Floxuridine - Floxuridine, a strong CYP2C9 inhibitor, may increase the serum concentration of Torasemide, a CYP2C9 substrate, by decreasing Torasemide metabolism and clearance. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of Torasemide if Floxuridine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00322 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00214_DB00322 assertion.
- drugbank:DB00214 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00214_DB00322 assertion.